Cell to extracellular matrix interactions and their reciprocal nature in cancer

Experimental Cell Research

Volumn 319, Issue 11, 2013, Pages 1663-1670

  Van Dijk, Marianne ^a   Göransson, Sara A ^a   Strömblad, Staffan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Contraction; ECM; Integrin; Remodelling; Stiffness; Tension

Indexed keywords

CELL ADHESION MOLECULE; FOCAL ADHESION KINASE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; INTEGRIN; INTEGRIN LINKED KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN CDC42; PROTEOGLYCAN; RAC1 PROTEIN; RHO FACTOR;

ANCHORAGE INDEPENDENT GROWTH; ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; BREAST BIOPSY; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL ANCHORAGE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; CYTOKINESIS; ELASTOGRAPHY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; INTRACELLULAR TRANSPORT; MECHANOTRANSDUCTION; MELANOMA; MESENCHYME CELL; METASTASIS; NEOPLASM; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; TUMOR MICROENVIRONMENT;

CONTRACTION; ECM; INTEGRIN; REMODELLING; STIFFNESS; TENSION;

ANIMALS; CELL COMMUNICATION; CELL PHYSIOLOGICAL PHENOMENA; EXTRACELLULAR MATRIX; HUMANS; NEOPLASMS;

EID: 84879602204     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.02.006     Document Type: Review

References (65)

1. Dolberg D.S., Hollingsworth R., Hertle M., Bissell M.J. Wounding and its role in RSV-mediated tumor formation. Science 1985, 230:676-678.
2. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 2012, 196:395-406.
3. Shah S.P., Roth A., Goya R., Oloumi A., Ha G., Zhao Y., Turashvili G., Ding J., Tse K., Haffari G., Bashashati A., Prentice L.M., Khattra J., Burleigh A., Yap D., Bernard V., McPherson A., Shumansky K., Crisan A., Giuliany R., Heravi-Moussavi A., Rosner J., Lai D., Birol I., Varhol R., Tam A., Dhalla N., Zeng T., Ma K., Chan S.K., Griffith M., Moradian A., Cheng S.W., Morin G.B., Watson P., Gelmon K., Chia S., Chin S.F., Curtis C., Rueda O.M., Pharoah P.D., Damaraju S., Mackey J., Hoon K., Harkins T., Tadigotla V., Sigaroudinia M., Gascard P., Tlsty T., Costello J.F., Meyer I.M., Eaves C.J., Wasserman W.W., Jones S., Huntsman D., Hirst M., Caldas C., Marra M.A, Aparicio S. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:395-399.
4. Heino J., Kapyla J. Cellular receptors of extracellular matrix molecules. Curr. Pharm. Des. 2009, 15:1309-1317.
5. Lock J.G., Wehrle-Haller B., Stromblad S. Cell-matrix adhesion complexes: master control machinery of cell migration. Semin. Cancer Biol. 2008, 18:65-76.
6. Legate K.R., Wickstrom S.A., Fassler R. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev. 2009, 23:397-418.
7. Cavalcanti-Adam E.A., Micoulet A., Blummel J., Auernheimer J., Kessler H., Spatz J.P. Lateral spacing of integrin ligands influences cell spreading and focal adhesion assembly. Eur. J. Cell Biol. 2006, 85:219-224.
8. Schwarz U.S., Gardel M.L. United we stand: integrating the actin cytoskeleton and cell-matrix adhesions in cellular mechanotransduction. J. Cell Sci. 2012, 125:3051-3060.
9. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
10. Petitclerc E., Stromblad S., von Schalscha T.L., Mitjans F., Piulats J., Montgomery A.M., Cheresh D.A., Brooks P.C. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res. 1999, 59:2724-2730.
11. Hsu M.Y., Shih D.T., Meier F.E., Van Belle P., Hsu J.Y., Elder D.E., Buck C.A., Herlyn M. Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am. J. Pathol. 1998, 153:1435-1442.
12. Assoian R.K., Klein E.A. Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol. 2008, 18:347-352.
13. Thullberg M., Gad A., Le Guyader S., Stromblad S. Oncogenic H-Ras V12 promotes anchorage-independent cytokinesis in human fibroblasts. Proc. Natl. Acad. Sci. USA 2007, 104:20338-20343.
14. Pellinen T., Tuomi S., Arjonen A., Wolf M., Edgren H., Meyer H., Grosse R., Kitzing T., Rantala J.K., Kallioniemi O., Fassler R., Kallio M., Ivaska J. Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev. Cell 2008, 15:371-385.
15. Klein E.A., Yin L., Kothapalli D., Castagnino P., Byfield F.J., Xu T., Levental I., Hawthorne E., Janmey P.A., Assoian R.K. Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening. Curr. Biol. 2009, 19:1511-1518.
16. Gad A., Thullberg M., Dannenberg J.H., te Riele H., Stromblad S. Retinoblastoma susceptibility gene product (pRb) and p107 functionally separate the requirements for serum and anchorage in the cell cycle G1-phase. J. Biol. Chem. 2004, 279:13640-13644.
17. Boudreau N., Werb Z., Bissell M.J. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA 1996, 93:3509-3513.
18. Leight J.L., Wozniak M.A., Chen S., Lynch M.L., Chen C.S. Matrix rigidity regulates a switch between TGF-beta1-induced apoptosis and epithelial-mesenchymal transition. Mol. Biol. Cell 2012, 23:781-791.
19. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 2010, 188:11-19.
20. Huttenlocher A., Horwitz A.R. Integrins in cell migration. Cold Spring Harb. Perspect. Biol. 2011, 3:a005074.
21. Sanz-Moreno V., Marshall C.J. The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr. Opin. Cell Biol. 2010, 22:690-696.
22. Xu J., Rodriguez D., Petitclerc E., Kim J.J., Hangai M., Moon Y.S., Davis G.E., Brooks P.C. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell Biol. 2001, 154:1069-1079.
23. Antia M., Islas L.D., Boness D.A., Baneyx G., Vogel V. Single molecule fluorescence studies of surface-adsorbed fibronectin. Biomaterials 2006, 27:679-690.
24. Provenzano P.P., Eliceiri K.W., Campbell J.M., Inman D.R., White J.G., Keely P.J. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006, 4:38.
25. Sinkus R., Lorenzen J., Schrader D., Lorenzen M., Dargatz M., Holz D. High-resolution tensor MR elastography for breast tumour detection. Phys. Med. Biol. 2000, 45:1649-1664.
26. Plodinec M., Loparic M., Monnier C.A., Obermann E.C., Zanetti-Dallenbach R., Oertle P., Hyotyla J.T., Aebi U., Bentires-Alj M., Lim R.Y., Schoenenberger C.A. The nanomechanical signature of breast cancer. Nat. Nanotechnol. 2012, 7:757-765.
27. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., Fong S.F., Csiszar K., Giaccia A., Weninger W., Yamauchi M., Gasser D.L., Weaver V.M. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
28. A.M. Baker, D. Bird, G. Lang, T.R. Cox, J.T. Erler, Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK, Oncogene, in press. http://dx.doi.org/10.1038/onc.2012.202.
29. Abbas O., Mahalingam M. Desmoplasia: not always a bad thing. Histopathology 2011, 58:643-659.
30. Michaloglou C., Vredeveld L.C., Mooi W.J., Peeper D.S. BRAF(E600) in benign and malignant human tumours. Oncogene 2008, 27:877-895.
31. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
32. Bourguignon L.Y. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin. Cancer Biol. 2008, 18:251-259.
33. Iozzo R.V., Sanderson R.D. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell. Mol. Med. 2011, 15:1013-1031.
34. Bourguignon L.Y., Singleton P.A., Zhu H., Diedrich F. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J. Biol. Chem. 2003, 278:29420-29434.
35. Bourguignon L.Y., Zhu H., Zhou B., Diedrich F., Singleton P.A., Hung M.C. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J. Biol. Chem. 2001, 276:48679-48692.
36. Reticker-Flynn N.E., Malta D.F., Winslow M.M., Lamar J.M., Xu M.J., Underhill G.H., Hynes R.O., Jacks T.E., Bhatia S.N. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat. Commun. 2012, 3:1122.
37. Kato H., Liao Z., Mitsios J.V., Wang H.Y., Deryugina E.I., Varner J.A., Quigley J.P., Shattil S.J. The primacy of beta1 integrin activation in the metastatic cascade. PLoS One 2012, 7:e46576.
38. Pellinen T., Rantala J.K., Arjonen A., Mpindi J.P., Kallioniemi O., Ivaska J. A functional genetic screen reveals new regulators of beta1-integrin activity. J. Cell Sci. 2012, 125:649-661.
39. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 2010, 11:288-300.
40. Lai M.T., Hua C.H., Tsai M.H., Wan L., Lin Y.J., Chen C.M., Chiu I.W., Chan C., Tsai F.J., Sheu J.Jinn-Chyuan Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis. J. Pathol. 2011, 224:367-376.
41. Desiniotis A., Kyprianou N. Significance of talin in cancer progression and metastasis. Int. Rev. Cell Mol. Biol. 2011, 289:117-147.
42. Meves A., Stremmel C., Gottschalk K., Fassler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol. 2009, 19:504-513.
43. Margadant C., Kreft M., de Groot D.J., Norman J.C., Sonnenberg A. Distinct roles of talin and kindlin in regulating integrin alpha5beta1 function and trafficking. Curr. Biol. 2012, 22:1554-1563.
44. Rantala J.K., Pouwels J., Pellinen T., Veltel S., Laasola P., Mattila E., Potter C.S., Duffy T., Sundberg J.P., Kallioniemi O., Askari J.A., Humphries M.J., Parsons M., Salmi M., Ivaska J. SHARPIN is an endogenous inhibitor of beta1-integrin activation. Nat. Cell Biol. 2011, 13:1315-1324.
45. Oxley C.L., Anthis N.J., Lowe E.D., Vakonakis I., Campbell I.D., Wegener K.L. An integrin phosphorylation switch: the effect of beta3 integrin tail phosphorylation on Dok1 and talin binding. J. Biol. Chem. 2008, 283:5420-5426.
46. Minden A. PAK4-6 in cancer and neuronal development. Cell. Logist. 2012, 2:95-104.
47. Li Z., Lock J.G., Olofsson H., Kowalewski J.M., Teller S., Liu Y., Zhang H., Stromblad S. Integrin-mediated cell attachment induces a PAK4-dependent feedback loop regulating cell adhesion through modified integrin alpha v beta 5 clustering and turnover. Mol. Biol. Cell 2010, 21:3317-3329.
48. Li Z., Zhang H., Lundin L., Thullberg M., Liu Y., Wang Y., Claesson-Welsh L., Stromblad S. p21-activated kinase 4 phosphorylation of integrin beta5 Ser-759 and Ser-762 regulates cell migration. J. Biol. Chem. 2010, 285:23699-23710.
49. Bridgewater R.E., Norman J.C., Caswell P.T. Integrin trafficking at a glance. J. Cell Sci. 2012, 125:3695-3701.
50. Zhang H., Berg J.S., Li Z., Wang Y., Lang P., Sousa A.D., Bhaskar A., Cheney R.E., Stromblad S. Myosin-X provides a motor-based link between integrins and the cytoskeleton. Nat. Cell Biol. 2004, 6:523-531.
51. Arjonen A., Kaukonen R., Ivaska J. Filopodia and adhesion in cancer cell motility. Cell Adh. Migr. 2011, 5:421-430.
52. Liu F., Mih J.D., Shea B.S., Kho A.T., Sharif A.S., Tager A.M., Tschumperlin D.J. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J. Cell Biol. 2010, 190:693-706.
53. Stricker J., Falzone T., Gardel M.L. Mechanics of the F-actin cytoskeleton. J. Biomech. 2010, 43:9-14.
54. Baneyx G., Baugh L., Vogel V. Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc. Natl. Acad. Sci. USA 2002, 99:5139-5143.
55. Lindahl G.E., Chambers R.C., Papakrivopoulou J., Dawson S.J., Jacobsen M.C., Bishop J.E., Laurent G.J. Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J. Biol. Chem. 2002, 277:6153-6161.
56. Wipff P.J., Rifkin D.B., Meister J.J., Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 2007, 179:1311-1323.
57. Shivashankar G.V. Mechanosignaling to the cell nucleus and gene regulation. Annu. Rev. Biophys. 2011, 40:361-378.
58. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., Zanconato F., Le Digabel J., Forcato M., Bicciato S., Elvassore N., Piccolo S. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474:179-183.
59. Vartiainen M.K., Guettler S., Larijani B., Treisman R. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 2007, 316:1749-1752.
60. Lambert C.A., Colige A.C., Munaut C., Lapiere C.M., Nusgens B.V. Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. Matrix Biol. 2001, 20:397-408.
61. Vega F.M., Ridley A.J. Rho GTPases in cancer cell biology. FEBS Lett. 2008, 582:2093-2101.
62. Lane J., Martin T.A., Watkins G., Mansel R.E., Jiang W.G. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int. J. Oncol. 2008, 33:585-593.
63. Croft D.R., Sahai E., Mavria G., Li S., Tsai J., Lee W.M., Marshall C.J., Olson M.F. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res. 2004, 64:8994-9001.
64. Samuel M.S., Lopez J.I., McGhee E.J., Croft D.R., Strachan D., Timpson P., Munro J., Schroder E., Zhou J., Brunton V.G., Barker N., Clevers H., Sansom O.J., Anderson K.I., Weaver V.M., Olson M.F. Actomyosin-mediated cellular tension drives increased tissue stiffness and beta-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011, 19:776-791.
65. Lochhead P.A., Wickman G., Mezna M., Olson M.F. Activating ROCK1 somatic mutations in human cancer. Oncogene 2010, 29:2591-2598.